Il y a eu 50 transactions d'initiés récentes enregistrées pour Adaptive Biotechnologies Corporation (ADPT), dont 16 achats et 34 ventes. Le total des achats d'initiés s'élève à $288.47K et le total des ventes d'initiés à $14.16M.
Les initiés notables ayant une activité récente comprennent Rubinstein Julie, Griffin Michelle Renee, Robins Chad M. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ADPT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-02 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
81,719 |
| 2026-04-01 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
96,441 |
| 2026-03-31 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
111,163 |
| 2026-03-30 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
125,885 |
| 2026-03-27 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
140,607 |
| 2026-03-26 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
155,329 |
| 2026-03-25 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
170,051 |
| 2026-03-24 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
184,773 |
| 2026-03-23 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$7.27 |
$107.03K |
199,495 |
| 2026-03-20 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
3,939 |
$6.55 |
$25.8K |
- |
| 2026-03-19 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
3,939 |
| 2026-03-18 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
18,661 |
| 2026-03-17 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
33,383 |
| 2026-03-16 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
48,105 |
| 2026-03-13 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
62,827 |
| 2026-03-12 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
77,549 |
| 2026-03-11 |
Griffin Michelle Renee |
Director |
Vente Informative |
15,394 |
$13.91 |
$214.13K |
15,625 |
| 2026-03-11 |
Robins Chad M |
CEO and Chairman |
Vente Informative |
329,600 |
$13.17 |
$4.34M |
2,301,113 |
| 2026-03-11 |
Lo Francis |
Chief People Officer |
Vente Informative |
30,593 |
$14.08 |
$430.75K |
291,374 |
| 2026-03-11 |
Piskel Kyle |
Chief Financial Officer |
Vente Informative |
18,672 |
$13.17 |
$245.91K |
259,840 |
| 2026-03-11 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
92,271 |
| 2026-03-11 |
Robins Harlan S |
Chief Scientific Officer |
Vente Informative |
329,600 |
$13.17 |
$4.34M |
1,522,058 |
| 2026-03-11 |
Benzeno Sharon |
Chief Commercial Ofc Imm Med |
Vente Informative |
63,103 |
$13.17 |
$831.07K |
272,751 |
| 2026-03-11 |
Bobulsky Susan |
Chief Commercial Officer, Mrd |
Vente Informative |
41,338 |
$13.17 |
$544.42K |
427,775 |
| 2026-03-10 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
106,993 |
| 2026-03-09 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
121,715 |
| 2026-03-06 |
Robins Chad M |
CEO and Chairman |
Attribution de RSU |
709,220 |
- |
- |
2,771,280 |
| 2026-03-06 |
Robins Harlan S |
Chief Scientific Officer |
Attribution de RSU |
709,220 |
- |
- |
1,992,324 |
| 2026-03-06 |
Rubinstein Julie |
President and COO |
Exercice d'Options (Vente) |
14,722 |
$6.55 |
$96.43K |
136,437 |
| 2026-03-05 |
Lo Francis |
Chief People Officer |
Vente Informative |
38,074 |
$15.09 |
$574.54K |
321,967 |
| 2026-03-04 |
Rubinstein Julie |
President and COO |
Exercice d'Options |
11,881 |
$12.14 |
$144.24K |
610,514 |
| 2026-03-04 |
Griffin Michelle Renee |
Director |
Attribution de RSU |
15,625 |
- |
- |
31,019 |
| 2026-03-04 |
Neupert Peter M |
Director |
Attribution de RSU |
15,625 |
- |
- |
240,315 |
| 2026-03-04 |
Hershberg Robert |
Director |
Attribution de RSU |
15,625 |
- |
- |
62,347 |
| 2026-03-04 |
Robins Chad M |
CEO and Chairman |
Attribution de RSU |
127,813 |
- |
- |
2,062,060 |
| 2026-03-04 |
Lo Francis |
Chief People Officer |
Attribution de RSU |
44,063 |
- |
- |
360,041 |
| 2026-03-04 |
Piskel Kyle |
Chief Financial Officer |
Attribution de RSU |
61,875 |
- |
- |
278,512 |
| 2026-03-04 |
Rubinstein Julie |
President and COO |
Attribution de RSU |
81,250 |
- |
- |
656,485 |
| 2026-03-04 |
Robins Harlan S |
Chief Scientific Officer |
Attribution de RSU |
127,813 |
- |
- |
1,283,104 |
| 2026-03-04 |
Benzeno Sharon |
Chief Commercial Ofc Imm Med |
Attribution de RSU |
39,063 |
- |
- |
335,854 |
| 2026-03-04 |
Bobulsky Susan |
Chief Commercial Officer, Mrd |
Attribution de RSU |
59,375 |
- |
- |
406,613 |
| 2026-03-04 |
Owen Katey Einterz |
Director |
Attribution de RSU |
15,625 |
- |
- |
88,254 |
| 2026-03-03 |
Griffin Michelle Renee |
Director |
Exercice d'Options (Vente) |
48,044 |
$3.99 |
$191.7K |
- |
| 2026-03-03 |
Rubinstein Julie |
President and COO |
Exercice d'Options |
11,881 |
$12.14 |
$144.24K |
614,852 |
| 2025-05-16 |
Piskel Kyle |
Chief Financial Officer |
Vente Informative |
1,929 |
$8.89 |
$17.15K |
277,396 |
| 2025-05-16 |
Piskel Kyle |
Chief Financial Officer |
Vente Informative |
1,929 |
$8.89 |
$17.15K |
269,581 |
| 2025-05-15 |
Piskel Kyle |
Chief Financial Officer |
Attribution de RSU |
7,815 |
- |
- |
279,325 |
| 2025-05-01 |
Robins Harlan S |
Chief Scientific Officer |
Exercice d'Options (Vente) |
68,412 |
$6.32 |
$432.36K |
- |
| 2025-03-24 |
Robins Harlan S |
Chief Scientific Officer |
Exercice d'Options (Vente) |
1,698 |
$6.32 |
$10.73K |
68,412 |
| 2025-03-14 |
Piskel Kyle |
Chief Financial Officer |
Exercice d'Options (Vente) |
2,500 |
$6.32 |
$15.8K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
